Benzinga | Apr 29, 2021 04:42PM EDT

Emergent BioSolutions Q1 EPS $1.53 Beats $1.12 Estimate, Sales $343.00M Miss $358.47M Estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $1.12 by 36.61 percent. This is a 15200 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $343.00 million which missed the analyst consensus estimate of $358.47 million by 4.32 percent. This is a 78.18 percent increase over sales of $192.50 million the same period last year.